Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concomitant MRI-detected and MRI-undetected Prostate Cancer with Implications for Biopsy Strategies and Focal Therapy Planning: An Analysis of the PROMIS and PICTURE Trials.

European urology oncology·2026
Same author

An advanced in vitro bladder cancer model integrating bladder cancer spheroids into a healthy human urothelium for preclinical therapeutic testing.

British journal of cancer·2026
Same author

The Imperial Prostate 9 - Approaches To Long-term Active Surveillance: Regular MRI scans versus standard of care (IP9-ATLAS) randomised controlled trial.

Contemporary clinical trials·2026
Same author

Diagnosis of penile cancer with ex vivo fluorescence confocal microscopy using the Histolog® Scanner.

BJU international·2026
Same author

Field effects in penile squamous cell carcinoma: Insights from Wnt-related protein expression.

Clinical and experimental dermatology·2026
Same author

Primary squamous cell carcinoma of the scrotum: an analysis of risk factors, histopathological characteristics and management of 10 patients from a specialist centre.

Clinical and experimental dermatology·2025

Related Experiment Video

Updated: Jul 10, 2026

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

Plexin-B1 mutations in prostate cancer.

Oscar Gee-Wan Wong1, Tharani Nitkunan, Izumi Oinuma

  • 1Prostate Cancer Research Centre, Institute of Urology, University College London, 67 Riding House Street, London W1W 7EJ, United Kingdom.

Proceedings of the National Academy of Sciences of the United States of America
|November 21, 2007
PubMed
Summary
This summary is machine-generated.

Mutations in the Plexin-B1 gene, a key player in cell movement signaling, were frequently found in prostate cancers. These genetic alterations enhance cancer cell motility and invasion, highlighting Plexin-B1

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

Related Experiment Videos

Last Updated: Jul 10, 2026

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Semaphorins are proteins that guide cell movement through plexin receptors.
  • Cancer cells may exploit semaphorin signaling for invasion and metastasis.

Purpose of the Study:

  • To investigate the role of the semaphorin signaling pathway, specifically Plexin-B1, in prostate cancer progression.

Main Methods:

  • Analysis of somatic mutations in the Plexin-B1 gene's cytoplasmic domain in prostate cancer samples (bone metastases, lymph node metastases, primary cancers).
  • Assessment of Plexin-B1 protein overexpression in primary tumors.
  • Functional studies to evaluate the impact of mutations on cell motility, invasion, adhesion, and lamellipodia extension.

Main Results:

  • Identified 13 somatic missense mutations in the Plexin-B1 cytoplasmic domain.
  • High mutation frequency observed in prostate cancer bone metastases (89%), lymph node metastases (41%), and primary cancers (46%).
  • Mutations were found to impair Rac and R-Ras binding and R-RasGAP activity, leading to increased cell motility, invasion, adhesion, and lamellipodia extension.
  • Plexin-B1 protein overexpression was detected in most primary tumors.

Conclusions:

  • Plexin-B1 mutations and overexpression play a significant role in prostate cancer.
  • The semaphorin signaling pathway mediated by Plexin-B1 is crucial for prostate cancer invasion and metastasis.